Chief Medical Officer · Syndax Pharmaceuticals Inc (SNDX)

Michael Meyers

A named executive officer of Syndax Pharmaceuticals in every fiscal year CompBrief holds from FY2017 to FY2019. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2019

$818,472

Salary $424,360Stock awards $0

FY2018: $1,051,934

3rd of 3 named executive officers at Syndax Pharmaceuticals by FY2019 total.

3 named officers on file for Syndax Pharmaceuticals, FY2019

Michael Meyers’s pay file — $29

  • 3 fiscal years of pay, line by line
  • SNDX’s disclosed peer group of 22 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Syndax Pharmaceuticals’s whole pay program stands against its peers

  • Syndax Pharmaceuticals’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on SNDX→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 29, 2020 (DEF 14A).

Free

Get Michael Meyers’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Michael Meyers compensation by year

Syndax Pharmaceuticals Summary Compensation Table · all 3 fiscal years held
In US dollars, as Syndax Pharmaceuticals reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2017FY2018FY2019
Salary$400,000$412,000$424,360
Bonus$0$0$0
Stock awards$0$0$0
Option awards$379,833$474,785$219,173
Non-equity incentive$132,700$144,200$152,770
Pension and deferred compensation$0$0$0
All other$21,047$20,949$22,169
Total$933,580$1,051,934$818,472

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Syndax Pharmaceuticals Inc DEF 14A filed April 29, 2020, accession 0001564590-20-019694, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Syndax Pharmaceuticals Inc filed document, accession 0001564590-20-019694. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2020.

$934K
$1.1M
$818K
FY17
FY18
FY19
SalaryNon-equity incentiveOption awardsAll other

Equity holdings

unvested awards at FY2019 year-end
TypeUnvested unitsValue at year-endExercise price
Option39,178—$6.38
Option39,063—$9.40
Option17,902—$8.77
Option53,500—$6.38

Per the Outstanding Equity Awards at Fiscal Year-End table in Syndax Pharmaceuticals Inc's FY2019 proxy; value at the fiscal year-end close, as the company printed it.

Syndax Pharmaceuticals’s named executive officers, FY2019

as the company reported each
Named executive officerRoleFY2019 total
Michael MetzgerChief Operating Officer$2,696,887
Briggs MorrisonChief Executive Officer$1,612,004
Michael Meyers · this pageChief Medical Officer$818,472

The full Syndax Pharmaceuticals compensation record

free company brief

This page is one person within Syndax Pharmaceuticals's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Syndax Pharmaceuticals proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Syndax Pharmaceuticals's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Michael Meyers's compensation dossier · One-time report. No refunds.